These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19060022)

  • 1. Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomised, crossover, double blind, placebo controlled inpatient trial.
    Willmott C; Ponsford J
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):552-7. PubMed ID: 19060022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of extended-release methylphenidate following traumatic brain injury: a randomised controlled pilot study.
    Dymowski AR; Ponsford JL; Owens JA; Olver JH; Ponsford M; Willmott C
    Clin Rehabil; 2017 Jun; 31(6):733-741. PubMed ID: 27353245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of methylphenidate following traumatic brain injury: impact on vital signs and side-effects during inpatient rehabilitation.
    Willmott C; Ponsford J; Olver J; Ponsford M
    J Rehabil Med; 2009 Jun; 41(7):585-7. PubMed ID: 19543672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial.
    Whyte J; Hart T; Vaccaro M; Grieb-Neff P; Risser A; Polansky M; Coslett HB
    Am J Phys Med Rehabil; 2004 Jun; 83(6):401-20. PubMed ID: 15166683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of COMT Val158Met genotype on attention and response to methylphenidate following traumatic brain injury.
    Willmott C; Ponsford J; McAllister TW; Burke R
    Brain Inj; 2013; 27(11):1281-6. PubMed ID: 23924290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.
    Adams J; Alipio-Jocson V; Inoyama K; Bartlett V; Sandhu S; Oso J; Barry JJ; Loring DW; Meador KJ
    Epilepsia; 2017 Dec; 58(12):2124-2132. PubMed ID: 28990169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury--a pilot study.
    Nikles CJ; McKinlay L; Mitchell GK; Carmont SA; Senior HE; Waugh MC; Epps A; Schluter PJ; Lloyd OT
    Trials; 2014 Feb; 15():54. PubMed ID: 24524676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial.
    Whyte J; Hart T; Schuster K; Fleming M; Polansky M; Coslett HB
    Am J Phys Med Rehabil; 1997; 76(6):440-50. PubMed ID: 9431261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
    Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.
    Turner DC; Blackwell AD; Dowson JH; McLean A; Sahakian BJ
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):286-95. PubMed ID: 15338103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial.
    McDonald BC; Flashman LA; Arciniegas DB; Ferguson RJ; Xing L; Harezlak J; Sprehn GC; Hammond FM; Maerlender AC; Kruck CL; Gillock KL; Frey K; Wall RN; Saykin AJ; McAllister TW
    Neuropsychopharmacology; 2017 Aug; 42(9):1766-1775. PubMed ID: 27874023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study.
    Plenger PM; Dixon CE; Castillo RM; Frankowski RF; Yablon SA; Levin HS
    Arch Phys Med Rehabil; 1996 Jun; 77(6):536-40. PubMed ID: 8831468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study.
    Kim YH; Ko MH; Na SY; Park SH; Kim KW
    Clin Rehabil; 2006 Jan; 20(1):24-30. PubMed ID: 16502746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Methylphenidate on Long-Term Neuropsychological and Everyday Executive Functioning After Traumatic Brain Injury in Children with Secondary Attention Problems.
    LeBlond E; Smith-Paine J; Riemersma JJ; Horn PS; Wade SL; Kurowski BG
    J Int Neuropsychol Soc; 2019 Aug; 25(7):740-749. PubMed ID: 31178001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate, cognition, and epilepsy: A double-blind, placebo-controlled, single-dose study.
    Adams J; Alipio-Jocson V; Inoyama K; Bartlett V; Sandhu S; Oso J; Barry JJ; Loring DW; Meador K
    Neurology; 2017 Jan; 88(5):470-476. PubMed ID: 28031390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial.
    Pride NA; Barton B; Hutchins P; Coghill DR; Korgaonkar MS; Hearps SJC; Rouel M; Malarbi S; North KN; Payne JM
    BMJ Open; 2018 Aug; 8(8):e021800. PubMed ID: 30166301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.
    Puymirat J; Bouchard JP; Mathieu J
    Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of methylphenidate in traumatic brain injury.
    Siddall OM
    Ann Pharmacother; 2005; 39(7-8):1309-13. PubMed ID: 15914519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery in pediatric brain injury: is psychostimulant medication beneficial?
    Williams SE; Ris MD; Ayyangar R; Schefft BK; Berch D
    J Head Trauma Rehabil; 1998 Jun; 13(3):73-81. PubMed ID: 9582180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.